U.S., June 18 -- An application to own the trademark for 'ANKTHEMBA' has been filed on Feb. 24, 2025.
Owner(s):
ImmunityBio, Inc.; 3530 John Hopkins Court, , CALIFORNIA
Goods and/or Services:
For: Pharmaceutical preparations for the treatment and prevention of lymphopenia; Pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; Pharmaceutical preparations for use in stimulating lymphocyte production; Pharmaceutical preparations for maintenance of lymphocyte counts
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-06-17&serialNumber=99053305
Disclaimer: ...